Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an IDEAL Framework to Standardise the Complex Intervention of Cytoreductive Surgery for Colorectal Peritoneal Metastases: a Necessary Step to Phase III Trials

NCT03733184 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT03733184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03733184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an IDEAL Framework to Standardise the Complex Intervention of Cytoreductive Surgery for Colorectal Peritoneal Metastases: a Necessary Step to Phase III Trials
Lead sponsor
University of Manchester
Phase
Observational
Overall status
Completed
Start date
March 10, 2016
Completion date
November 30, 2019
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, peritoneal metastases